Hyperinsulinism, one of the most important causes of hypoglycaemia, can be congenital or acquired. Rarely, drug toxicity can be a reason for hyperinsulinism. In the context of Munchausen syndrome by proxy (MSP), toxicity usually occurs in children due to drug administration by a parent or caregiver. A 7-year-old girl was referred to our department due to a hyperglycaemic period and hypoglycaemic episodes. On admission, gliclazide was initiated due to her hyperglycaemia, which we attributed to maturity onset diabetes of the young. However, during follow-up, hypoglycaemic levels were detected. Despite cessation of gliclazide, hypoglycaemic seizures occurred. Even with the medications administered, hypoglycaemia could not be prevented. During follow-up, the mother's affect, characterized by anxiety and interest in her daughter's medical care, appeared discordant with the situation. Due to our suspicion of MSP, we discovered toxic levels of gliclazide in the blood and urine samples which had been sent to the toxicology laboratory to search for hypoglycaemic agents. The patient was isolated, and all medications were stopped. After isolation, her hypoglycaemia disappeared, and she became hyperglycaemic (250 mg/dl). Physicians should consider the possibility of MSP in hyperinsulinaemic patients with discordant laboratory results and clinical symptoms, even if the child's parents display great concern.

Keywords:
Gliclazide, Hyperinsulinism, Hypoglycaemia, Munchausen syndrome, Proxy
1.
Bauman WA, Yalow RS: Child abuse: parenteral insulin administration. J Pediatr 1981;99:588-591.
2.
Kovacs CS, Toth EL: Factitious diabetes mellitus and spontaneous hypoglycemia. Consequences of unrecognized Munchausen syndrome by proxy. Diabetes Care 1993;16:1294-1297.
3.
Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM: GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 2004;34:535-542.
4.
Hussain K: Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy. Horm Res 2008;69:2-13.
5.
Horev A, Haim A, Zvulunov A: Propranolol induced hypoglycemia. Pediatr Endocrinol Rev 2015;12:308-310.
6.
Spiller HA, Villalobos D, Krenzelok EP, Anderson BD, Gorman SE, Rose SR, Fenn J, Anderson DL, Muir SJ, Rodgers GC Jr: Prospective multicenter study of sulfonylurea ingestion in children. J Pediatr 1997;131:141-146.
7.
Meadow R: Different interpretations of Munchausen syndrome by proxy. Child Abuse Negl 2002;26:501-508.
8.
McClure RJ, Davis PM, Meadow SR, Sibert JR: Epidemiology of Munchausen syndrome by proxy, non-accidental poisoning, and non-accidental suffocation. Arch Dis Child 1996;75:57-61.
9.
Sigal M, Gelkopf M, Meadow RS: Munchausen by proxy syndrome: the triad of abuse, self-abuse, and deception. Compr Psychiatry 1989;30:527-533.
10.
Owen L, Ellis M, Shield J: Deliberate sulphonylurea poisoning mimicking hyperinsulinaemia of infancy. Arch Dis Child 2000;82:392-393.
11.
Caruso M, Bregani P, Di Natale B, D'Arcais A: Induced hypoglycemia. A unusual case of child battering. Minerva Pediatr 1989;41:525-528.
12.
Aranibar H, Cerda M: Hypoglycemic seizure in Munchausen-by-proxy syndrome. Pediatr Emerg Care 2005;21:378-379.
13.
Glatstein M, Garcia-Bournissen F, Scolnik D, Koren G, Finkelstein Y: Hypoglycemia in a healthy toddler. Ther Drug Monit 2009;31:173-177.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.